Generics
Upsher-Smith Laboratories launches Ramelteon Tablets 8mg
16 December 2020 -

Upsher-Smith Laboratories LLC, a United States-based pharmaceutical company, has introduced its Ramelteon Tablets, 8mg, it was reported on Tuesday.

Upsher-Smith's product is AB-rated to the branded product, ROZEREM (ramelteon) tablets. The product is intended for the treatment of insomnia characterised by difficulty with sleep onset.

Rusty Field, president and CEO, Upsher-Smith, said, 'Expanding Upsher-Smith's portfolio of generic drug products and providing patients access to affordable generic medicines continues to be a priority. The launch of Ramelteon, the company's sixth generic product launch this year, clearly demonstrates the incredible resolve of our team in helping achieve these milestones during an unprecedented time.'

Login
Username:

Password: